Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$143K Sell
207,318
-368,498
-64% -$358K ﹤0.01% 2846
2025
Q4
$582K Buy
+575,816
New +$817K ﹤0.01% 2180

Other funds holding NVX

Marshall Wace's NVX Position: Q1 2026 in Review

Marshall Wace reduced its NOVONIX (NVX) stake by 64% in Q1 2026, selling an estimated $358K and leaving 207,318 shares worth $143K. The position accounts for ﹤0.01% of the portfolio, ranked #2846.

Marshall Wace first reported a position in NVX in Q4 2025 and has held it in 2 quarters since. The position peaked at $582K in Q4 2025. 32 funds tracked by Wall St. Rank hold NVX as of Q1 2026.

  • Marshall Wace held 207,318 shares of NOVONIX worth $143K as of Q1 2026.
  • Marshall Wace sold 368,498 NOVONIX shares in Q1 2026, an estimated $358K.
  • NOVONIX made up ﹤0.01% of Marshall Wace's portfolio in Q1 2026, its #2846 holding.
  • Marshall Wace first reported a position in NOVONIX in Q4 2025 and has held it in 2 quarters since.
  • Marshall Wace's NOVONIX position peaked at $582K in Q4 2025.
  • 32 funds tracked by Wall St. Rank held NOVONIX as of Q1 2026.

Based on Marshall Wace's 13F filing for Q1 2026, filed 15 May 2026.